Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALL vs GSK✓SelectedUSD · GSKALL vs GSK performance historyLatest closeAs of+1.04%11/16
Stock and ETF performance explorer

ALL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+168.8%
GSK return
+47.4%
Excess return
+121.5%
Maximum drawdown
-27.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.0%-0.1%+1.1%+1.1%
7D+6.6%-1.3%+7.9%+6.9%
30D+9.1%+2.7%+6.4%+8.4%
3M+3.9%+2.7%+1.2%+3.2%
6M+25.6%+3.3%+22.3%+24.5%
YTD+31.8%+6.5%+25.3%+29.6%
1Y+28.6%+10.7%+18.0%+25.4%
3Y+113.3%+64.4%+49.0%+89.3%
All+168.8%+47.4%+121.5%+138.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling